LINK ALTERNATIF MBL77 - AN OVERVIEW

Not all clients with CLL demand therapy. Irrespective of all current advancements, the iwCLL nevertheless recommends watchful observation for individuals with asymptomatic disorder.86 This advice relies on not less than two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).